Tower Research Capital (TRC)’s HI-TECH PHARMACAL INC HITK Stock Holding History

Tower Research Capital (TRC)’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-92	Closed	-$4K	–	5328
2014 Q1	$4K	Sell	92 -662	-88%	-$28.7K	﹤0.01%	3554
2013 Q4	$33K	Buy	754 +339	+82%	+$14.7K	0.01%	1809
2013 Q3	$18K	Buy	+415	New	+$15.9K	﹤0.01%	2798

Tower Research Capital (TRC)'s HITK Position: Q2 2014 in Review

Tower Research Capital (TRC) sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 92 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in HITK in Q3 2013 and held it in 3 quarters. The position peaked at $33K in Q4 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Tower Research Capital (TRC) reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Tower Research Capital (TRC) sold 92 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $4K.
Tower Research Capital (TRC) first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 3 quarters.
Tower Research Capital (TRC)'s HI-TECH PHARMACAL INC position peaked at $33K in Q4 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.